Luminex Shares Drop, Bruker Pares Losses | GenomeWeb
Shares in Luminex dropped 9 percent for the five-day trading period ended Tuesday. The firm’s shares have declined 13 percent since closing at $14.35 on May 2, the day it released its first-quarter results, which included a 28 percent gain in revenues but a 75 percent drop in profit year over year. Luminex led the 10 stocks that lost value during the trading period.
Bruker BioSciences reversed a two-week skid in its share price and closed up 8 percent for the week.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.